Tilbage til menuen

Publikationer 2006

Ph.d.-afhandling

Caroline Kistorp: Prevalence and prognostic impact of diabetes mellitus and obesity in patients with chronic heart failure - relation to biomarkers of endothelial function, inflammation and adipose tissue. Forsvaret februar 2006.

Videnskabelige artikler

1. Home PD, Hallgren P, Usadel KH, Sane T, Faber J, Grill V, Friberg HH. Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes. Diabetes Res Clin Pract 2006; 71(2):131-9

2. Gustafsson I, Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt PR, Macleod K, Laakso M, Torp-Pedersen C, Waldenström A for DIGAMI 2 investigatorerne. Metabolisk kontrol med insulin hos patienter med diabetes mellitus og akut myokardieinfarkt (DIGAMI 2): effekt på mortalitet og morbiditet - sekndær publikation. Ugeskr Laeger 2006;168: 581-4

3. Kragelund CB, Groning BA, Kober L, Hildebrandt PR, Steffensen R. Prognostisk værdi af N-terminal pro B-type natriuretisk peptid hos patienter med stabil iskæmisk hjertesygdom - sekundærpublikation. Ugeskr Laeger 2006;168(7):697-700

4. Kragelund C, Gronning B. Omland T, Kober L, Strande S, Steffensen R, Hildebrandt P. Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stabl coronary disease? Am Heart J 2006;151(3):712.e1-712.e7

5, Olsen MH, Christensen MK, Hansen TW, Gustafsson F, Rasmussen S, Wachtell K, Borch-Johnsen K, Ibsen H, Jorgensen T, Hildebrandt P. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors. J Hypertens 2006;24(4):655-661

6. Schou M, Gustafsson F, Nielsen PH, Madsen LH, Kjaer A, Hildebrandt PR. Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state. Eur J Heart Fail. 2006 Jul 6; [Epub ahead of print]

7. Kragelund C, Gustafsson I, Omland T, Gronning B, Kober L, Faber J, Strande S, Steffensen R, Hildebrandt P. Prognostic value of NH2-terminal pro B-type natriuretic peptide in patients with diabetes and stable coronary heart disease. Diabetes Care 2006;29:1411-3

8. Damgaard M, Norsk P, Gustafsson F, Kanters JK, Christensen NJ, Bie P, Friberg L, Gadsboll N. Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Intergr Comp Physiol. 2006;290:R1294-301

9. L.H. Madsen, G. Christensen, T. Lund, V.L. Serebruany, C.B. Granger, I. Hoen, Z. Grieg, J.H. Alexander, A.S. Jaffe, J.E. Van Eyk, D. Atar. Time-Course of Degradation of Cardiac Troponin I in Patients with Acute ST-Elevation Myocardial Infarction: The ASSENT-2 Troponin Substudy. Circulation Research. 2006.99;1141.

10. Kragelund C, Omland T. Biology of natriuretic peptides. In “Cardiovascular Biomarkers, Pathophysiology and Disease Management. Edited by David A. Morrow. Humana Press 2006


Publikationer 2007

Ph.d.-afhandling

Lene Madsen: Troponiner hos nyreinsufficiente patienter. I samarbejde med Professor Dan Atar, Hjertemedicinsk afdeling, Ullevål Sjukhus, Oslo, Norge. Indskrevet som ph.d. studerende på Københavns Universitetet. Forsvaret 2007.

Videnskabelige artikler

1. Corell P et al. Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction.
Eur J Heart Fail. 2007 Mar;9(3):258-65

2. Corell P et al. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure. Int J Cardiol. 2007 May 2;117(3):395-402

3. Schou M et al. Long-term clinical variation of NT-proBNP in stable chronic heart failure patients.
Eur Heart J. 2007 Jan;28(2):177-82.

4. Schou M et al. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure.
Am Heart J. 2007 Jul;154(1):123-9.

5. Madsen LH et al. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
Kidney Int. 2007 Mar;71(6):548-54.

6. Gustafsson et al. Treatment with beta-blockers in nurse-led heart failure clinics: Titration efficacy and predictors of failure. Eur J Heart Fail. 2007 Jun 13; [Epub ahead of print]

7. Schou et al. Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state.
Eur J Heart Fail. 2007 Jan;9(1):68-74.

8. Corell P. Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction.
Eur J Heart Fail. 2007 Mar;9(3):258-65.

9. Corell P et al. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure.
Int J Cardiol. 2007 May 2;117(3):395-402.




Redaktør
Webredaktion
Email DiguTLIZGgmY@tAC.regionh.dk



Kontakt

Medicinsk Afdeling
Frederiksberg Hospital
Nordre Fasanvej 57
Hovedvejen, indgang 12 
2000 Frederiksberg

Telefonnumre

Se afdeling på kort

Se afdeling på kort